New: NCI-funded clinical trial search
Mednet Logo
CommunityPediatric Hematology/Oncology

Pediatric Hematology/Oncology

Clinical discussions on pediatric blood disorders, childhood cancers, and specialized treatment protocols.

Recent Discussions

How will you use Pola-R-CHP in the frontline treatment of DLBCL?

4
3 Answers

Mednet MemberInvited Expert
Medical Oncology · Cleveland Clinic

Given the comparable toxicity profile and the lower rate of treatment failure, the number needed to treat (n=16) is low enough that this is very appropriate to be the new standard of care. Although overall survival was not different, fewer patients treated with the Pola-R-CHP regimen required subseq...

How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?

2 Answers

Mednet MemberInvited Expert
Hematology · Mayo Clinic

This can be a complex question for which there are likely no specific data or guidelines upon which to base a recommendation. ASH has published guidelines on thrombophilia testing in VTE (Middeldorp et al., PMID 37195076). They specifically recommend against testing prior to COC prescription. The ra...

Is your standard of care for newly diagnosed advanced classical Hodgkin now nivolumab-AVD based on SWOG 1826?

5 Answers

Mednet MemberInvited Expert
Medical Oncology · Lurie Comp Cancer Center of Northwestern Univ

I think the new standard of care for newly diagnosed patients with advanced classical Hodgkins Lymphoma is now nivolumab-AVD based on the early data from SWOG 1826. While we often wait for more mature data, the early improvement in PFS and the more favorable toxicity profile of this regimen over BvA...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

How would you manage a child with subtotal resection of an atypical choroid plexus papilloma?

2 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · C. S. Mott Children’s Hospital, University of Michigan

Data from the SickKids Hospital study strongly suggest that the extent of resection is prognostic in atypical CPP, and in the presence of GTR, chemotherapy may be avoided or skipped entirely (Browne-Farmer et al., PMID 34529227). The role of adjuvant treatment in the setting of incompletely resected...

When do you consider including Rituximab into the treatment regimen for a pediatric or AYA patient with intermediate and advanced-stage nodular lymphocyte-predominant Hodgkin lymphoma?

1 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · University of Colorado School of Medicine Anschutz Medical Campus

First, I would want to make sure the diagnosis is correct as advanced stage NLPHL is extremely rare. T-cell rich B-cell lymphoma can look identical histologically. Either way, R-CHOP therapy is good therapy for both.

How would you manage a recurrent pineoblastoma following prior CSI?

1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Cleveland Clinic

Recurrent pineoblastoma following prior CSI represents a challenging clinical scenario. As there is very little published data to guide optimal management, our approach is adopted from recurrent medulloblastoma. The prognosis for patients with recurrent medulloblastoma/PNET is poor, with 5-year OS <...

Can aplastic anemia present with multiple infiltrative bone lesions, such as in the spine and pelvis?

3 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · St. Jude Children's Research Hospital

There are several studies showing diffuse hypointense pictures with an infiltrative-like pattern on MRI in aplastic anemia and MDS. Some aplastic anemia and refractory cytopenia of childhood show patchy pattern of hematopoiesis with some regions having increased fat fraction and some remnants of hem...

What is your therapy of choice for relapsed metastatic alveolar rhabdomyosarcoma?

1 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · Children's Mercy Hospitals and Clinics

I will make just a couple of presumptions. First, I will presume that this alveolar rhabdo is FOXO1-fusion positive. If not, I would treat as I would an embryonal (fusion negative) rhabdo with vinorelbine/PO cyclophosphamide, vinorelbine/cyclo/temsirolimus, vincristine/irinotecan +/- temozolomide, c...

What is the role of radiotherapy in a newly diagnosed patient with parameningeal rhabdomyosarcoma w/ intracranial extension, a positive CSF but no extra-CNS metastases?

1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Stanford University School of Medicine

The question as to the role of RT in patients with parameningeal (PM) RMS with CNS leptomeningeal disease is complex and one lacking scientific evidence to support one’s answer. My response represents a historic viewpoint gained from hearing the discussions of the Intergroup Rhabdomyosarcoma Group (...

How do you approach relapsed idiopathic HLH?

2 Answers

Mednet MemberInvited Expert
Hematology · Harvard Medical School

If the patient was previously in remission after etoposide and steroids, they may well respond to etoposide and steroids again. I strongly consider hematopoietic stem cell transplant in anyone who relapses after an episode of HLH, since it is usually a harbinger of recurrent and potentially life-thr...